British multinational pharmaceutical and biotechnology company
Kory Swanson joins Matthew Elliott, CEO of the Vote Leave group in the Brexit campaign, to discuss at National Review Online the continuing importance of British-American trade. Elliott will expand…
It is well known that a huge part of the cost of labor for American business is health insurance. A small firm employing as few as 15 or 20 people…
View in your browser. In June, the US Supreme Court struck down a provision of the Los Angeles Municipal Code. The Court held that, under the Fourth Amendment’s prohibition of…
Earlier this month, the US District Court of the Southern District of New York announced its decision in Amarin Pharma, Inc. v. FDA. As healthcare economist John Goodman reports in…
I love stories about entrepreneurs who take risks and thrive, thanks to capitalism. In this case, it’s a Cary businesswoman. Wedding Story Writer, a company formed in 2011, creates an heirloom product…
If you’ve read Peter Schweizer’s Throw Them All Out or any one of Don Carrington’s various chronicles of Carolina corruption, you might see how Raleigh and our nation’s capital might…
More than 4,000 Durham-area kids got a back-to-school boost from the Durham Rescue Mission and GlaxoSmithKline. Supplies, clothing, and hot dogs were all part of the annual event — and…
North Carolina’s plutocracy has semi-officially decided to get behind health care overhaul despite vast and numerous problems in the bills and implementation. Brad Wilson, incoming CEO of the state’s quasi-public…
We’re all hoping the swine flu scare is just that — a scare — and not an enormous outbreak around the world and in this country. The economy responds to…
Not that anyone needs it, but Glaxo is laying off folks after being yet another company to get money from the taxpayers. The following is just kind of funny/sad Two…
When government steps in with regulations to prohibit and slow production of pharmaceutical companies, jobs are lost and advances in medicine are slowed. According to a Triangle Business Journal report…
E-phemeridem??!! Does Glaxo Smith Kline make that one, Jon? Ask your doctor if E-phemeridim is right for you.